SI20473A - Tienilazolilalkoksietanamini, njihova priprava in njihova uporaba kot zdravila - Google Patents

Tienilazolilalkoksietanamini, njihova priprava in njihova uporaba kot zdravila Download PDF

Info

Publication number
SI20473A
SI20473A SI9920030A SI9920030A SI20473A SI 20473 A SI20473 A SI 20473A SI 9920030 A SI9920030 A SI 9920030A SI 9920030 A SI9920030 A SI 9920030A SI 20473 A SI20473 A SI 20473A
Authority
SI
Slovenia
Prior art keywords
methyl
general formula
pyrazole
thienylmethyl
dimethylamino
Prior art date
Application number
SI9920030A
Other languages
English (en)
Slovenian (sl)
Inventor
Ramon Merce-Vidal
Blas Andaluz-Mataro
Constansa Jordi Frigola
Original Assignee
Laboratorios Del Dr. Esteve, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Del Dr. Esteve, S.A. filed Critical Laboratorios Del Dr. Esteve, S.A.
Publication of SI20473A publication Critical patent/SI20473A/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI9920030A 1998-04-15 1999-04-15 Tienilazolilalkoksietanamini, njihova priprava in njihova uporaba kot zdravila SI20473A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009800793A ES2150353B1 (es) 1998-04-15 1998-04-15 Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
PCT/ES1999/000098 WO1999052525A1 (es) 1998-04-15 1999-04-15 Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos

Publications (1)

Publication Number Publication Date
SI20473A true SI20473A (sl) 2001-08-31

Family

ID=8303465

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9920030A SI20473A (sl) 1998-04-15 1999-04-15 Tienilazolilalkoksietanamini, njihova priprava in njihova uporaba kot zdravila

Country Status (31)

Country Link
US (3) US6410582B1 (is)
EP (1) EP1072266B8 (is)
JP (1) JP2002511412A (is)
KR (1) KR100523366B1 (is)
CN (1) CN1189170C (is)
AR (1) AR016210A1 (is)
AT (1) ATE302604T1 (is)
AU (1) AU754705B2 (is)
BG (1) BG64891B1 (is)
BR (1) BR9910124A (is)
CA (1) CA2328878A1 (is)
CO (1) CO5011045A1 (is)
CU (1) CU22960A3 (is)
CZ (1) CZ298222B6 (is)
EE (1) EE04739B1 (is)
ES (1) ES2150353B1 (is)
GE (1) GEP20032913B (is)
HU (1) HUP0102585A3 (is)
IS (1) IS5662A (is)
LT (1) LT4830B (is)
LV (1) LV12624B (is)
NO (1) NO320313B1 (is)
NZ (1) NZ507573A (is)
PL (1) PL343512A1 (is)
RO (1) RO121690B1 (is)
RU (1) RU2213743C2 (is)
SI (1) SI20473A (is)
SK (1) SK285039B6 (is)
TW (1) TW528756B (is)
UA (1) UA58589C2 (is)
WO (1) WO1999052525A1 (is)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) * 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.
US6432954B1 (en) * 2000-07-14 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
ES2174756B2 (es) * 2001-04-06 2003-11-16 Esteve Labor Dr Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.
ES2180449B1 (es) * 2001-07-06 2004-01-16 Esteve Labor Dr Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
CL2004001034A1 (es) 2003-05-14 2005-03-28 Teijin Pharma Ltd Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
WO2006010627A1 (en) * 2004-07-30 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1632227A1 (en) * 2004-09-07 2006-03-08 Laboratorios del Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
EP1671968A1 (en) 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1828175A2 (en) * 2004-12-17 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
ES2303795B1 (es) * 2004-12-27 2009-06-12 Laboratorios Del Dr. Esteve, S.A. Procedimiento para obtener enantiomeros de tienilazolilalcoxietanaminas.
WO2006069767A1 (en) * 2004-12-27 2006-07-06 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1674465A1 (en) 2004-12-27 2006-06-28 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1743890A1 (en) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US20070149590A1 (en) * 2005-08-05 2007-06-28 Garcia Francisco J L Controlled release dosage form of pirazole compounds
EP1820502A1 (en) 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
CN102432845B (zh) * 2011-08-22 2013-03-13 电子科技大学 聚3,4-双乙基羟基噻吩气敏材料及其制备方法
EP3233805B1 (en) 2014-12-15 2019-02-06 Esteve Pharmaceuticals, S.A. Methyl-1h-pyrazole-alkylamine compounds having multimodal activity against pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613720B1 (fr) * 1987-04-10 1990-01-19 Esteve Labor Dr Derives d'aryl-heteroaryl carbinols avec activite analgesique
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.

Also Published As

Publication number Publication date
IS5662A (is) 2000-10-13
NO20005146D0 (no) 2000-10-13
CZ298222B6 (cs) 2007-07-25
ES2150353A1 (es) 2000-11-16
EP1072266B8 (en) 2006-10-18
NO20005146L (no) 2000-12-14
BG64891B1 (bg) 2006-08-31
CA2328878A1 (en) 1999-10-21
HUP0102585A3 (en) 2002-04-29
US20020188017A1 (en) 2002-12-12
PL343512A1 (en) 2001-08-27
ATE302604T1 (de) 2005-09-15
EE200000596A (et) 2002-06-17
CO5011045A1 (es) 2001-02-28
GEP20032913B (en) 2003-03-25
AU754705B2 (en) 2002-11-21
BR9910124A (pt) 2001-01-09
AR016210A1 (es) 2001-06-20
KR20010042739A (ko) 2001-05-25
AU3148399A (en) 1999-11-01
SK285039B6 (sk) 2006-05-04
EP1072266A1 (en) 2001-01-31
NO320313B1 (no) 2005-11-21
JP2002511412A (ja) 2002-04-16
LV12624A (lv) 2001-03-20
EE04739B1 (et) 2006-12-15
US6410582B1 (en) 2002-06-25
RU2213743C2 (ru) 2003-10-10
CN1303283A (zh) 2001-07-11
LT2000097A (en) 2001-03-26
US7129361B2 (en) 2006-10-31
CZ20003764A3 (en) 2001-05-16
ES2150353B1 (es) 2001-07-01
HUP0102585A2 (hu) 2001-12-28
US20040162324A1 (en) 2004-08-19
BG104853A (en) 2001-04-30
TW528756B (en) 2003-04-21
EP1072266B1 (en) 2005-08-24
WO1999052525A1 (es) 1999-10-21
SK15282000A3 (sk) 2001-12-03
CN1189170C (zh) 2005-02-16
CU22960A3 (es) 2004-06-21
LV12624B (lv) 2001-09-20
RO121690B1 (ro) 2008-02-28
LT4830B (lt) 2001-08-27
NZ507573A (en) 2002-07-26
UA58589C2 (uk) 2003-08-15
KR100523366B1 (ko) 2005-10-20

Similar Documents

Publication Publication Date Title
SI20473A (sl) Tienilazolilalkoksietanamini, njihova priprava in njihova uporaba kot zdravila
CA3017388C (en) Estrogen receptor modulators
US5948777A (en) Cannabinoid receptor agonists
EP1641763B1 (fr) Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application comme antagonistes des recepteurs aux cannabinoides cb1
FR2741621A1 (fr) Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
FI86175B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenolderivat.
FR2595695A1 (fr) Derives de n-(((hydroxy-2 phenyl) (phenyl) methylene) amino-2) ethyl) acetamide, leur preparation et leur application en therapeutique
JPS6377856A (ja) 新規なフェニル、ピロリジン―2―イル置換5員複素環化合物およびその製造方法並びにこの化合物を有効成分とする抗精神病医薬組成物
CA2000247A1 (fr) Derives de methyl-4 ¬(phenyl-4 piperazinyl-1)-2 ethyl -5| thiazole, leur procede de preparation et les compositions pharmaceutiques, en contenant
FR2911136A1 (fr) Derives de n-(4-cyano-1h-pyrazol-3-yl)methylamine substitues leur preparation et leur application en therapeutique.
FR2888236A1 (fr) Derives de n-[(1,5-diphenyl-1h-pyrazol-3-yl)methyl] sulfonamide, leur preparation et leur application en therapeutique
WO2009004171A2 (fr) Dérives de 1 -benzylpyrazole, leur preparation et leur application en therapeutique
JPH09508917A (ja) フェニルピロール誘導体およびそのドーパミンd▲下3▼アンタゴニストとしての使用
FR2692894A1 (fr) Aryl-1-(o-alcoxy-phényl-4-pipérazinyl-1)-2, 3- ou 4-alcanols, leur procédé de préparation et leur utilisation pour la préparation de médicaments.
JPS62267269A (ja) ピラゾ−ル−3−アミン類
MXPA00010055A (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
DE69926874T2 (de) Thienylazolylalkoxyethanamine, deren herstellung und deren verwendung als medikamente
CA2019464A1 (en) Bis (benzylpyrrolidine) derivatives as dopamine agonists
JPH02286675A (ja) アゾール―1―アルカンアミドおよびそれらの製法
HRP920775A2 (hr) Novi heterociklični spojevi koji sadrže dušik i sumpor, farmaceutski preparati koji ih sadrže i postupci za dobivanje

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20081208